AstraZeneca is a global, research-based biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. The company's core therapeutic areas include oncology, cardiovascular, renal and metabolism, respiratory and immunology, infectious disease, and rare disease. AstraZeneca operates a robust R&D pipeline with 183 projects, leveraging advanced technologies like cell therapy, oligonucleotide therapeutics, and AI-driven drug discovery. The company is committed to sustainability, with initiatives like AZ Forest and health equity programs, and maintains a strong global presence with science centers in Cambridge, Gothenburg, and Gaithersburg.
AstraZeneca serves healthcare professionals, patients, investors, researchers, and potential employees. It provides medical information for healthcare providers, clinical trial resources for patients, and investment insights for shareholders. The company also engages with suppliers and partners through its open innovation initiatives.
AstraZeneca stands out due to its significant investment in transformative technologies and its focus on sustainability and health equity. The company has a strong pipeline with recent positive Phase III programs and multiple first approvals in major markets. Its commitment to science is evident in its global R&D centers and collaborations, aiming to deliver innovative medicines that address unmet medical needs worldwide.
AstraZeneca operates in the highly competitive global pharmaceutical industry, alongside major players like Pfizer, Novartis, and Roche. It also collaborates with biotech firms and academic institutions. The company differentiates itself through its focus on oncology and rare diseases, as well as its sustainability initiatives, which are increasingly important in the industry.
L'Oréal
Kao Corporation
Shiseido
WebMD
Mayo Clinic
HSE University
